Skip to content

Author

Soumya Jena

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Double-dose intravitreal faricimab in resistant neovascular age-related macular degeneration: safety and efficacy

Anti-VEGF therapy remains the mainstay treatment for neovascular age-related macular degeneration (nAMD), yet a subset of eyes exhibit resistance to standard treatment regimens. This study evaluates the safety and efficacy of double-dose intravitreal faricimab (12 mg) in a series of eyes with nAMD refractory to b...

A. L. Ali, N. Mehta, M. Morsy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.